DIRS.INFO The most relevant business & tech news

Mike Kratky, 33, Leerink PartnersLeerink PartnersSector: Medical devices and technologyKratky's young career underwent a major shift in March 2020 — and it wasn't remote work. The Colgate University graduate thinks he's a better analyst for it because he now understands how readers of his research think. "The stock calls won't always go my way," Kratky said. All eight of the outperform-rated medtech stocks Leerink has covered since October have outperformed the S&P 500 and their industry index. The medtech industry is experiencing rapid change, particularly with the advent of GLP-1 drugs that treat obesity and diabetes.

Persons: Mike Kratky, Kratky, Leerink, He's, he's, Kratky's, — James Faris Organizations: Leerink Partners Leerink Partners, Nasdaq, Riley Securities, Colgate University, Tandem Diabetes Care Locations: Leerink

☆ Why this top banker left Goldman Sachs to help fund women who are changing healthcare
▼ + stars: | 2023-09-08 | by ( Blake Dodge | ) www.businessinsider.com time to read: +8 min

At Leerink Partners, Sasha Kelemen runs an investment-banking team unlike any other on Wall Street. For her work, Insider named Kelemen to our list of 30 leaders under 40 transforming healthcare. After graduating from business school at the University of Virginia in 2017, she joined the healthcare team at Goldman Sachs. Sasha Kelemen. Sasha Kelemen with her daughters Olivia and Zoe.

Persons: Sasha Kelemen, Goldman Sachs, Kelemen, Goldman, she'd, scrappy, Chris, who'd, Barry Blake, Blake, Wall, she's, Sasha Kelemen's, who's, they're, Leerink, it's, haven't, Olivia, Zoe, Jill Angelo, wasn't Organizations: Leerink Partners, Morning, University of Virginia, Boston College, Goldman, Wall, Investment, OB Locations: Venezuela, Florida, Connecticut, SVB, New York City, women's

☆ The Investing Club's top 10 things to watch in the stock market Friday
▼ + stars: | 2023-07-21 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

The Club's top 10 things to watch Friday, July 21 1. Morgan Stanley raised its price target on Eli Lilly to $560 a share, up from $551. KeyBanc raised its price target on Club holding Palo Alto Networks (PANW) to $285 a share, from $242, while maintaining an overweight weighting on the stock. Stifel raised its price target on Club holding Meta Platforms (META) to $336 a share, from $280, while maintaining a buy rating on the stock. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: it's, Z, Morgan Stanley, Eli Lilly, KeyBanc, SLB, Halliburton, SVB Leerink, Johnson, Stifel, DA Davidson, Jim Cramer's, Jim Cramer, Jim Organizations: Nasdaq, American Express, Novo Nordisk, Palo Alto Networks, Johnson, . Railroad, CSX, Microsoft, Jim Cramer's Charitable, CNBC Locations: millennials

☆ Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict
▼ + stars: | 2023-07-21 | by ( Paulina Likos | ) www.cnbc.com time to read: +7 min

But on Tuesday, J & J was ordered to pay $18.8 million after jurors found in favor of 24-year-old Emory Hernandez Valadez who claimed in his lawsuit that he developed mesothelioma, a deadly cancer linked to asbestos, from exposure to J & J talc products. J & J has said that over 60,000 claimants support its latest $8.9 billion settlement to be paid out over 25 years. Johnson & Johnson issued an official statement following the verdict in favor of Valdez, intending to appeal. Even so, J & J got a few of price target increases on Wall Street on Friday. The higher growth pharmaceuticals and medical technology businesses are remaining as the new J & J.

Persons: Johnson, J's, Jim Cramer, Jim, J, Emory Hernandez Valadez, we're, there's, Moshe Maimon, Levy, Maimon, Michael Kaplan, Kaplan, Erik Haas, Thursday's, Haas, Jim Cramer's, Justin Sullivan Organizations: Johnson, LTL Management, J, Credit Suisse, AAA, CNBC, & ' $, & $ Locations: California, American, Levy Konigsberg, Valdez, Stifel, Kenvue, San Anselmo , California

☆ A juicy lawsuit offers a window into a Wall Street hiring raid after HSBC took 40+ bankers from the remnants of SVB
▼ + stars: | 2023-05-22 | by ( Matt Turner | ) www.businessinsider.com time to read: +4 min

HSBC hired more than 40 SVB bankers after the California bank was acquired out of receivership. First Citizens, which acquired SVB in the US, is now suing HSBC. The lawsuit offers a rare window into a Wall Street hiring raid. That's at the heart of a new lawsuit accusing HSBC of poaching more than 40 bankers from the failed California bank. Around March 21, per the lawsuit, Sabow met with several of the core leaders he had identified to discuss Project Colony.

☆ SVB is still looking for a buyer. Here is what we know so far.
▼ + stars: | 2023-03-13 | by ( Hayley Cuccinello | ) www.businessinsider.com time to read: +5 min

The weekend came and went without a buyer for SVB Financial Group, the parent company of the failed Silicon Valley Bank. SVB Capital focuses on venture capital and credit investing and SVB Securities is its investment banking arm. Axios reported Monday morning that JPMorgan and PNC were in talks to acquire SVB Financial Group but not the failed commercial bank. SVB Securities, better known as SVB Leerink, the investment banking arm born out of SVB's 2018 acquisition of Leerink, is a very desirable business, he added. "SVB Leerink is a well-known name in the tech and healthcare space that will be attractive to someone," said Healy.

☆ Who will step up to buy SVB? The white knight might be a bank outside Wall Street.
▼ + stars: | 2023-03-11 | by ( Hayley Cuccinello | ) www.businessinsider.com time to read: +5 min

SVB Bank, which catered to startups and tech founders, imploded in three days after a run on the bank. SVB Financial is reportedly looking to find a buyer by Monday. The implosion of Silicon Valley Bank means a working weekend for some bankers. SVB Financial Group is on the hunt for a buyer after regulators closed its Silicon Valley Banking business, according to Bloomberg. Though SVB's bond losses are taking up the headlines, its parent company SVB Financial has two business segments that are enticing.

☆ How SVB employees are coping after being ordered to leave the office, from polishing their resumes to hitting the bar: 'We're pretty much in the dark'
▼ + stars: | 2023-03-10 | by ( Emmalyse Brownstein | Rebecca Ungarino | Carter Johnson | ) www.businessinsider.com time to read: +6 min

It read: "Operations of the SVB Securities broker dealer are distinct from the receivership of SVB Financial." The SVB Securities employee called the whirlwind leading up to SVB's meltdown as "scary, scary stuff." Kevin Heal, senior analyst at Argus Research, said he sees both SVB Securities and SVB Private being sold. SVB bought the healthcare investment bank Leerink Partners in 2018, renaming it SVB Leerink and then SVB Securities. PATRICK T. FALLON/AFP via Getty ImagesHeal thinks the investment banking operations could be purchased by a smaller investment banking firm that doesn't have tech or healthcare prowess, like US Bancorp or PNC.

☆ Analysis: Falling demand for COVID boosters puts price hikes on the table
▼ + stars: | 2022-10-20 | by ( Michael Erman | ) www.reuters.com time to read: +5 min

Last year, many on Wall Street were estimating the number of COVID-19 shots would be in line with the annual flu vaccine, which is the vaccine market leader with more than 160 million shots per year in the United States and 600 million shots globally. A recent poll by Kaiser Family Foundation found that two-thirds of American adults do not plan on getting a COVID vaccine soon. He added that instances of COVID infections in those who have been vaccinated has left many to question the effectiveness of the vaccine. The companies could make up for some of the weaker demand with price increases. That would mean annual revenue of $3 billion to $5 billion over the long-term for a company like Moderna, he added.

☆ Profituri de miliarde din afacerile cu vaccin
▼ + stars: | 2021-03-24 | by ( ) capital.market.md time to read: +9 min

Analiştii SVB Leerink estimează vânzări de 1,9 miliarde de dolari în acest an şi 3 miliarde de dolari în 2022. Acestea ar urma să fie mult mai mari dacă AstraZeneca va livra ambiţioasa sa ţintă de 3 miliarde de doze. La 4 martie, R. Moldova a recepţionat 14 400 doze de vaccin AstraZeneca livrate gratuit în cadrul mecanismului COVAX. Ministerul mai informează că, prin intermediul platformei COVAX, R. Moldova va primi 24 570 doze de vaccin Pfizer şi 264 000 doze de vaccin AstraZeneca. Anterior 21 600 doze de vaccin AstraZeneca au fost livrate, ca ajutor umanitar, din România, din cele 200 000 doze de vaccin promise.

Persons: Agenţia, Pfizer, Alan Carr, Johnson, Analiştii, Preţul, Aureliu Ciocoi, Janssen, Tatiana Zatîc, Vlad Organizations: euro, SUA, Pandemia, Medical Electronics, Guardian, Reuters, Uniunea Europeană, UE, Moderna, Uniunii Europene, Financial Times, Naţionale, Comitetului, OMS, Sk Bio, Center, Sputnik Locations: UE, FMI, SUA, Germania, China, preţul, Indonezia, Ungaria, Slovacia, Iran, Algeria, Mexic, Rusiei, Rusia, Republica Moldova, Moldova, România, şedinţă, UK, Sinopharm, Sinovac, Moderna

Search resuls for: "SVB Leerink"

10 mentions found